Effects of ionic remodeling on cardiac antiarrhythmic drug actions.
Nattel
S
S
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D015536:Down-Regulation; D004553:Electric Conductivity; D006333:Heart Failure / Q000503:physiopathology; D006801:Humans; D007473:Ion Channels / Q000378:metabolism*; D017136:Ion Transport / Q000187:drug effects; D008012:Lidocaine / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D026902:Potassium Channel Blockers / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D013612:Tachycardia, Ectopic Atrial / Q000378:metabolism / Q000503:physiopathology; D016171:Torsades de Pointes / Q000209:etiology
D000889:Anti-Arrhythmia Agents; D007473:Ion Channels; D026902:Potassium Channel Blockers; D008012:Lidocaine; C042288:pilsicainide